UM1TR005454
Cooperative Agreement
Overview
Grant Description
Ctsa program at University of Massachusetts - project summary/abstract
The UMCCTS was funded in 2010 with the vision of building healthier communities together through translational innovation.
Our mission is to advance learning and discovery to solve translational science challenges and improve well-being by:
1) Catalyzing, rigorously testing, and disseminating evidence-driven approaches that remove translational science (TS) roadblocks to efficient, high quality, and impactful translational research (TR); and
2) Building a workforce of skilled professional staff and investigators capable of changing paradigms in TS and TR.
As Massachusetts’ only public university system (UMass) partnered with 3 large clinical systems (UMass Memorial Health; Baystate Health; Lahey Health), we share an enduring focus on public engagement and societal benefit.
The UMCCTS engages a broad range of interest holders (communities, patient groups, foundations, industry, NCATS, and CTSA hubs) to ensure that the research we support and workforce we train address problems important to the communities we serve.
With our partners, we identify important problems and needs, develop and validate enabling platforms, and provide resources that facilitate transdisciplinary team science.
We use data and analytics to generate knowledge, apply that knowledge to improve performance, then use lessons learned to inform and refine the next improvement cycle.
UMCCTS workforce development programs ensure the future sustainability of the TS enterprise.
Our four specific aims correspond to NCATS strategic goals stated in the NCATS NOFO and build on our prior successes:
Aim 1: Promote individual and community health by building community-centered systems and approaches that expand and sustain the engagement of participants, communities, and research teams;
Aim 2: Develop a robust set of digital tools and informatics systems that engage a broad range of study participants, promote data sharing, enable actionable insights, and that extend our learning health system across partners and into home and community settings;
Aim 3: Provide resources that overcome TS and operational barriers to continuously improve the quality, efficiency, and impact of TR across the spectrum;
Aim 4: Advance the development of a skilled TS workforce through innovative educational curricula, transdisciplinary team-based training, and career development programs.
By working with our partners on each of these aims we will accomplish our overarching goal of speeding the development of evidence-based, real-world approaches that promote health, treat disease, and respond to urgent public health needs locally, regionally, and nationally.
The UMCCTS was funded in 2010 with the vision of building healthier communities together through translational innovation.
Our mission is to advance learning and discovery to solve translational science challenges and improve well-being by:
1) Catalyzing, rigorously testing, and disseminating evidence-driven approaches that remove translational science (TS) roadblocks to efficient, high quality, and impactful translational research (TR); and
2) Building a workforce of skilled professional staff and investigators capable of changing paradigms in TS and TR.
As Massachusetts’ only public university system (UMass) partnered with 3 large clinical systems (UMass Memorial Health; Baystate Health; Lahey Health), we share an enduring focus on public engagement and societal benefit.
The UMCCTS engages a broad range of interest holders (communities, patient groups, foundations, industry, NCATS, and CTSA hubs) to ensure that the research we support and workforce we train address problems important to the communities we serve.
With our partners, we identify important problems and needs, develop and validate enabling platforms, and provide resources that facilitate transdisciplinary team science.
We use data and analytics to generate knowledge, apply that knowledge to improve performance, then use lessons learned to inform and refine the next improvement cycle.
UMCCTS workforce development programs ensure the future sustainability of the TS enterprise.
Our four specific aims correspond to NCATS strategic goals stated in the NCATS NOFO and build on our prior successes:
Aim 1: Promote individual and community health by building community-centered systems and approaches that expand and sustain the engagement of participants, communities, and research teams;
Aim 2: Develop a robust set of digital tools and informatics systems that engage a broad range of study participants, promote data sharing, enable actionable insights, and that extend our learning health system across partners and into home and community settings;
Aim 3: Provide resources that overcome TS and operational barriers to continuously improve the quality, efficiency, and impact of TR across the spectrum;
Aim 4: Advance the development of a skilled TS workforce through innovative educational curricula, transdisciplinary team-based training, and career development programs.
By working with our partners on each of these aims we will accomplish our overarching goal of speeding the development of evidence-based, real-world approaches that promote health, treat disease, and respond to urgent public health needs locally, regionally, and nationally.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Worcester,
Massachusetts
01655
United States
Geographic Scope
Single Zip Code
University Of Massachusetts Medical School was awarded
UMCCTS Translational Science Program: Advancing Health and Innovation
Cooperative Agreement UM1TR005454
worth $5,955,258
from National Center for Advancing Translational Sciences in March 2026 with work to be completed primarily in Worcester Massachusetts United States.
The grant
has a duration of 6 years 10 months and
was awarded through assistance program 93.350 National Center for Advancing Translational Sciences.
The Cooperative Agreement was awarded through grant opportunity Clinical and Translational Science Award (UM1 Clinical Trial Optional).
Status
(Ongoing)
Last Modified 3/5/26
Period of Performance
3/1/26
Start Date
1/31/33
End Date
Funding Split
$6.0M
Federal Obligation
$0.0
Non-Federal Obligation
$6.0M
Total Obligated
Activity Timeline
Additional Detail
Award ID FAIN
UM1TR005454
SAI Number
UM1TR005454-2824862675
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NR00 NIH National Center for Advancing Translational Sciences
Funding Office
75NR00 NIH National Center for Advancing Translational Sciences
Awardee UEI
MQE2JHHJW9Q8
Awardee CAGE
6R004
Performance District
MA-02
Senators
Edward Markey
Elizabeth Warren
Elizabeth Warren
Modified: 3/5/26